MSH2 gene
The MSH2 gene was identified as a locus frequently mutated in hereditary nonpolyposis colon cancer (HNPCC).
Genetests:
Research |
Method |
Carrier testing |
Turnaround |
5 days |
Specimen type |
genomic DNA |
Related Diseases:
References:
1. |
Wijnen J et al. (1995) Seven new mutations in hMSH2, an HNPCC gene, identified by denaturing gradient-gel electrophoresis.
|
2. |
Lynch HT et al. (2004) A founder mutation of the MSH2 gene and hereditary nonpolyposis colorectal cancer in the United States.
|
3. |
Barana D et al. (2004) Spectrum of genetic alterations in Muir-Torre syndrome is the same as in HNPCC.
|
4. |
Chan TL et al. (2004) MSH2 c.1452-1455delAATG is a founder mutation and an important cause of hereditary nonpolyposis colorectal cancer in the southern Chinese population.
|
5. |
Duval A et al. (2004) The mutator pathway is a feature of immunodeficiency-related lymphomas.
|
6. |
Kovtun IV et al. (2004) Somatic deletion events occur during early embryonic development and modify the extent of CAG expansion in subsequent generations.
|
7. |
Wada-Hiraike O et al. (2005) The DNA mismatch repair gene hMSH2 is a potent coactivator of oestrogen receptor alpha.
|
8. |
van der Klift H et al. (2005) Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC).
|
9. |
Sun S et al. (2005) The HNPCC associated MSH2*1906G-->C founder mutation probably originated between 1440 CE and 1715 CE in the Ashkenazi Jewish population.
|
10. |
Chan TL et al. (2006) Heritable germline epimutation of MSH2 in a family with hereditary nonpolyposis colorectal cancer.
|
11. |
Stella A et al. (2007) Germline novel MSH2 deletions and a founder MSH2 deletion associated with anticipation effects in HNPCC.
|
12. |
Kets CM et al. (2009) Compound heterozygosity for two MSH2 mutations suggests mild consequences of the initiation codon variant c.1A>G of MSH2.
|
13. |
Lishanski A et al. (1994) Mutation detection by mismatch binding protein, MutS, in amplified DNA: application to the cystic fibrosis gene.
|
14. |
Reitmair AH et al. (1995) MSH2 deficient mice are viable and susceptible to lymphoid tumours.
|
15. |
de Wind N et al. (1995) Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer.
|
16. |
Kolodner RD et al. (1994) Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for msh2 mutations.
|
17. |
Vilkki S et al. (2001) Extensive somatic microsatellite mutations in normal human tissue.
|
18. |
Mary JL et al. (1994) Mutational analysis of the hMSH2 gene reveals a three base pair deletion in a family predisposed to colorectal cancer development.
|
19. |
Orth K et al. (1994) Genetic instability in human ovarian cancer cell lines.
|
20. |
Fishel R et al. (1994) Binding of mismatched microsatellite DNA sequences by the human MSH2 protein.
|
21. |
Liu B et al. (1994) hMSH2 mutations in hereditary nonpolyposis colorectal cancer kindreds.
|
22. |
Aquilina G et al. (1994) A mismatch recognition defect in colon carcinoma confers DNA microsatellite instability and a mutator phenotype.
|
23. |
Umar A et al. (1994) Defective mismatch repair in extracts of colorectal and endometrial cancer cell lines exhibiting microsatellite instability.
|
24. |
Fishel R et al. (1993) The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer.
|
25. |
Leach FS et al. (1993) Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer.
|
26. |
Jeon HM et al. (1996) Mutation of the hMSH2 gene in two families with hereditary nonpolyposis colorectal cancer.
|
27. |
Lowsky R et al. (1997) Defects of the mismatch repair gene MSH2 are implicated in the development of murine and human lymphoblastic lymphomas and are associated with the aberrant expression of rhombotin-2 (Lmo-2) and Tal-1 (SCL).
|
28. |
Pearson CE et al. (1997) Human MSH2 binds to trinucleotide repeat DNA structures associated with neurodegenerative diseases.
|
29. |
Esche C et al. (1997) Muir-Torre syndrome: clinical features and molecular genetic analysis.
|
30. |
Gradia S et al. (1997) The human mismatch recognition complex hMSH2-hMSH6 functions as a novel molecular switch.
|
31. |
DeWeese TL et al. (1998) Mouse embryonic stem cells carrying one or two defective Msh2 alleles respond abnormally to oxidative stress inflicted by low-level radiation.
|
32. |
Jin YH et al. (2003) Cadmium is a mutagen that acts by inhibiting mismatch repair.
|
33. |
Wang Y et al. (2000) BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures.
|
34. |
Ellison AR et al. (2001) Functional analysis of human MLH1 and MSH2 missense variants and hybrid human-yeast MLH1 proteins in Saccharomyces cerevisiae.
|
35. |
Mangold E et al. (2004) A genotype-phenotype correlation in HNPCC: strong predominance of msh2 mutations in 41 patients with Muir-Torre syndrome.
|
36. |
Alazzouzi H et al. (2005) Low levels of microsatellite instability characterize MLH1 and MSH2 HNPCC carriers before tumor diagnosis.
|
37. |
Quehenberger F et al. (2005) Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment.
|
38. |
Pagenstecher C et al. (2006) Aberrant splicing in MLH1 and MSH2 due to exonic and intronic variants.
|
39. |
Kurzawski G et al. (2006) Germline MSH2 and MLH1 mutational spectrum including large rearrangements in HNPCC families from Poland (update study).
|
40. |
Barnetson RA et al. (2006) Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer.
|
41. |
Tournier I et al. (2008) A large fraction of unclassified variants of the mismatch repair genes MLH1 and MSH2 is associated with splicing defects.
|
42. |
Maliaka YK et al. (1996) CpG dinucleotides in the hMSH2 and hMLH1 genes are hotspots for HNPCC mutations.
|
43. |
Genuardi M et al. (1998) Characterization of MLH1 and MSH2 alternative splicing and its relevance to molecular testing of colorectal cancer susceptibility.
|
44. |
Ricciardone MD et al. (1999) Human MLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type 1.
|
45. |
Wang Q et al. (1999) Neurofibromatosis and early onset of cancers in hMLH1-deficient children.
|
46. |
Froggatt NJ et al. (1999) A common MSH2 mutation in English and North American HNPCC families: origin, phenotypic expression, and sex specific differences in colorectal cancer.
|
47. |
Gradia S et al. (1999) hMSH2-hMSH6 forms a hydrolysis-independent sliding clamp on mismatched DNA.
|
48. |
Yuan ZQ et al. (1999) A missense mutation in both hMSH2 and APC in an Ashkenazi Jewish HNPCC kindred: implications for clinical screening.
|
49. |
McMurray CT et al. (2003) Cancer, cadmium and genome integrity.
|
50. |
Pyatt RE et al. (2003) Identification of a deletion in the mismatch repair gene, MSH2, using mouse-human cell hybrids monosomal for chromosome 2.
|
51. |
Wagner A et al. (2003) Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene.
|
52. |
Wheeler VC et al. (2003) Mismatch repair gene Msh2 modifies the timing of early disease in Hdh(Q111) striatum.
|
53. |
Bougeard G et al. (2003) Early onset brain tumor and lymphoma in MSH2-deficient children.
|
54. |
Foulkes WD et al. (2002) The founder mutation MSH2*1906G-->C is an important cause of hereditary nonpolyposis colorectal cancer in the Ashkenazi Jewish population.
|
55. |
Brown KD et al. (2003) The mismatch repair system is required for S-phase checkpoint activation.
|
56. |
Wagner A et al. (2002) A 10-Mb paracentric inversion of chromosome arm 2p inactivates MSH2 and is responsible for hereditary nonpolyposis colorectal cancer in a North-American kindred.
|
57. |
Wang Y et al. (2002) A modified multiplex PCR assay for detection of large deletions in MSH2 and MLH1.
|
58. |
Whiteside D et al. (2002) A homozygous germ-line mutation in the human MSH2 gene predisposes to hematological malignancy and multiple café-au-lait spots.
|
59. |
Lamers MH et al. (2000) The crystal structure of DNA mismatch repair protein MutS binding to a G x T mismatch.
|
60. |
Desai DC et al. (2000) Recurrent germline mutation in MSH2 arises frequently de novo.
|
61. |
Yan H et al. (2000) Conversion of diploidy to haploidy.
|
62. |
Ni TT et al. (1999) MSH2 and MSH6 are required for removal of adenine misincorporated opposite 8-oxo-guanine in S. cerevisiae.
|
63. |
Orphanet article
Orphanet ID 123487
|
64. |
NCBI article
NCBI 4436
|
65. |
OMIM.ORG article
Omim 609309
|
66. |
Wikipedia article
Wikipedia EN (MSH2)
|
Update: Aug. 14, 2020